TrialFrontiers in immunology2025

Pilot clinical trial of neoadjuvant toll-like receptor 7 agonist (Imiquimod) immunotherapy in early-stage oral squamous cell carcinoma.

Angela J Yoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.